EP2969006 - COMPOSITIONS AND METHODS FOR TREATING AN IMMUNODEFICIENCY VIRUS INFECTION [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 15.03.2019 Database last updated on 06.07.2024 | |
Former | Examination is in progress Status updated on 27.04.2018 | ||
Former | Request for examination was made Status updated on 20.06.2017 | Most recent event Tooltip | 15.03.2019 | Application deemed to be withdrawn | published on 17.04.2019 [2019/16] | Applicant(s) | For all designated states The J. David Gladstone Institutes 1650 Owens Street San Francisco, CA 94158 / US | [2016/03] | Inventor(s) | 01 /
WEINBERGER, Leor S. 945 Sunnyhills Road Oakland, CA 94610 / US | 02 /
NOTTON, Timothy J. 1844 Fell Street San Francisco, California 94117 / US | [2016/03] | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [N/P] |
Former [2016/03] | Brasnett, Adrian Hugh, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | Application number, filing date | 14770952.1 | 13.03.2014 | [2016/03] | WO2014US26423 | Priority number, date | US201361784844P | 14.03.2013 Original published format: US 201361784844 P | [2016/03] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014151771 | Date: | 25.09.2014 | Language: | EN | [2014/39] | Type: | A1 Application with search report | No.: | EP2969006 | Date: | 20.01.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.09.2014 takes the place of the publication of the European patent application. | [2016/03] | Search report(s) | International search report - published on: | US | 25.09.2014 | (Supplementary) European search report - dispatched on: | EP | 06.10.2016 | Classification | IPC: | A61P31/18, C12N15/113 | [2016/03] | CPC: |
A61K35/76 (EP,US);
A61K38/162 (EP,US);
A61K39/12 (EP,US);
A61K39/21 (EP,US);
A61P31/18 (EP);
C12N7/00 (US);
C12N2740/16021 (EP,US);
C12N2740/16032 (EP,US);
C12N2740/16033 (US);
C12N2740/16062 (US)
(-)
| C-Set: |
A61K35/76, A61K2300/00 (EP,US);
A61K38/162, A61K2300/00 (US,EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/03] | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG EINER IMMUNSCHWÄCHEVIRUSINFEKTION | [2016/03] | English: | COMPOSITIONS AND METHODS FOR TREATING AN IMMUNODEFICIENCY VIRUS INFECTION | [2016/03] | French: | COMPOSITIONS ET PROCÉDÉS POUR TRAITER UNE INFECTION PAR UN VIRUS D'IMMUNODÉFICIENCE | [2016/03] | Entry into regional phase | 21.08.2015 | National basic fee paid | 21.08.2015 | Search fee paid | 21.08.2015 | Designation fee(s) paid | 21.08.2015 | Examination fee paid | Examination procedure | 21.08.2015 | Examination requested [2016/03] | 25.08.2017 | Amendment by applicant (claims and/or description) | 02.05.2018 | Despatch of a communication from the examining division (Time limit: M06) | 13.11.2018 | Application deemed to be withdrawn, date of legal effect [2019/16] | 10.12.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2019/16] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 02.05.2018 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 25.08.2017 | Request for further processing filed | 25.08.2017 | Full payment received (date of receipt of payment) Request granted | 04.09.2017 | Decision despatched | Fees paid | Renewal fee | 31.03.2016 | Renewal fee patent year 03 | 27.03.2017 | Renewal fee patent year 04 | 27.03.2018 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI] - MARIO R. MAUTINO ET AL, "Modified Human Immunodeficiency Virus-Based Lentiviral Vectors Display Decreased Sensitivity to Trans -Dominant Rev", HUMAN GENE THERAPY, US, (20000410), vol. 11, no. 6, doi:10.1089/10430340050015509, ISSN 1043-0342, pages 895 - 908, XP055305178 [X] 1-6,8-14 * abstract * * page 895 - page 900 * [I] 15 DOI: http://dx.doi.org/10.1089/10430340050015509 | [XI] - E. OLIVETTA ET AL, "cis Expression of the F12 Human Immunodeficiency Virus (HIV) Nef Allele Transforms the Highly Productive NL4-3 HIV Type 1 to a Replication-Defective Strain: Involvement of both Env gp41 and CD4 Intracytoplasmic Tails", JOURNAL OF VIROLOGY., US, (20000101), vol. 74, no. 1, doi:10.1128/JVI.74.1.483-492.2000, ISSN 0022-538X, pages 483 - 492, XP055305176 [X] 1-4,7-9,11-14 * abstract * * page 483 - page 484 * * page 487 - page 491 * [I] 15 DOI: http://dx.doi.org/10.1128/JVI.74.1.483-492.2000 | International search | [Y]US6248721 (CHANG LUNG-JI [US]); | [Y]US2003064071 (LITTMAN DAN R [US], et al); | [Y]US2010015087 (ENSOLI BARBARA [IT]); | [Y]WO2011146612 (UAB RESEARCH FOUNDATION [US], et al); | [Y]WO2012019991 (INST NAT SANTE RECH MED [FR], et al); | [X] - ROUZINE, I. ET AL., "Design Requirements For Interfering Particles To Maintain Coadaptive Stability With HIV-1.", J. VIROL., (20121205), vol. 87, no. 4;, pages 2081 ; PAGES 2081 - 2093, XP055283053 DOI: http://dx.doi.org/10.1128/JVI.02741-12 | [Y] - D'COSTA, J ET AL., "Human Immunodeficiency Virus Type 2 Lentiviral Vectors: Packaging Signal And Splice Donor In Expression And Encapsidation.", JOUMAL OF GENERAL VIROLOGY., (2001), vol. 82, pages 425 - 434, XP002969190 |